临床试验中放射治疗质量保证的建议
该建议基于丹麦多学科癌症小组(DMCG)临床试验中放射治疗质量保证(RTQA)的经验,为主要研究者(PI)规划和执行临床试验RTQA提供推荐,并包含一份帮助PI制定有效RTQA计划的清单。
要点
- 建议源于丹麦多学科癌症小组临床试验的RTQA经验。
- 推荐包含一份指导PI制定有效RTQA计划的清单。
- 稳健的RTQA可减少治疗实施的不确定性,增强研究统计效力。
核心结论
- 为PI规划和执行临床试验RTQA提供推荐,并包含一份指导PI制定有效RTQA计划的清单。
研究设计与样本
- 基于丹麦多学科癌症小组(DMCG)临床试验中RTQA经验的建议。
主要发现
- 随着RT技术发展且更复杂,为特定临床试验建立合适的QA计划日益具有挑战性,凸显清晰标准化建议的重要性。
关键数值与推荐
- 推荐包含一份指导PI制定有效RTQA计划的清单。
临床怎么用
- PI在规划和执行临床试验RTQA时可参考本建议及所附清单。
局限性
- 原文未述局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Robust quality assurance (QA) of clinical trials in radiotherapy (RT) is paramount for minimising uncertainties in treatment delivery, thereby strengthening the statistical power of the study and increasing the likelihood of accurately answering the research question. As RT techniques evolve and become more complex, establishing an appropriate QA program for a specific clinical trial becomes increasingly challenging, highlighting the importance of clear and standardised recommendations. This study provide such recommendations for Principal Investigators (PIs) to consider when planning and conducting RT Quality Assurance (RTQA) for clinical trials. They arise from experiences with RTQA in the clinical trials conducted in the Danish Multidisciplinary Cancer Groups (DMCGs). The recommendations include a checklist to guide PIs in developing an effective RTQA program.
引用
- Nielsen CP, Samsøe E, Offersen BV, et al. Recommendations for radiotherapy quality assurance in clinical trials. Radiother Oncol. 2025. PMID: 40412533. doi:10.1016/j.radonc.2025.110950
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。